Clevidipine butyrate CAS: 167221-71-8
Catalog Number | XD93864 |
Product Name | Clevidipine butyrate |
CAS | 167221-71-8 |
Molecular Formula | C21H23Cl2NO6 |
Molecular Weight | 456.32 |
Storage Details | Ambient |
Product Specification
Appearance | White powder |
Assay | 99% min |
Clevidipine butyrate is a medication that falls under the class of calcium channel blockers. It is primarily used for the rapid control of blood pressure in patients who require immediate intervention. This intravenous medication is known for its rapid onset and short duration of action, making it particularly useful in emergency situations or during surgery.Clevidipine butyrate works by selectively blocking calcium channels in the smooth muscles surrounding blood vessels. By inhibiting the entry of calcium into these cells, it relaxes and dilates the blood vessels, leading to a decrease in peripheral vascular resistance. This mechanism ultimately results in a reduction in blood pressure.Due to its specific pharmacological properties, clevidipine butyrate offers several advantages. First, its rapid onset of action allows for immediate control of high blood pressure. This can be crucial in situations like hypertensive emergencies or during anesthesia induction, where swift blood pressure control is necessary. Additionally, its short duration of action allows for rapid adjustment and titration of the medication to maintain optimal blood pressure levels while minimizing the risk of hypotension or adverse effects.Clevidipine butyrate is commonly used in the perioperative setting, especially during cardiovascular surgery. It provides effective blood pressure control during surgical procedures and can be easily adjusted based on individual patient needs. The rapid metabolism and elimination of the drug also make it an attractive choice in this setting, as it minimizes the risk of prolonged postoperative hypotension.Another potential use of clevidipine butyrate is in the management of acute ischemic stroke. Studies have shown that prompt control of blood pressure in patients experiencing acute ischemic stroke can be beneficial for their outcomes. Clevidipine butyrate's ability to rapidly lower blood pressure makes it a suitable option for this purpose, although more research is needed to establish its optimal role in stroke management.Overall, clevidipine butyrate is a valuable medication for the rapid control of blood pressure in critical situations. Its quick onset, short duration of action, and titratable nature make it an effective tool for managing high blood pressure during surgeries, hypertensive emergencies, and potentially even for acute ischemic stroke. However, as with any medication, it is important to use clevidipine butyrate under the guidance and supervision of a healthcare professional.